Deep cervical abscesses in children: efficacy of the cefotaxime-rifampicin combination.


Journal

European journal of pediatrics
ISSN: 1432-1076
Titre abrégé: Eur J Pediatr
Pays: Germany
ID NLM: 7603873

Informations de publication

Date de publication:
May 2023
Historique:
received: 12 12 2022
accepted: 02 03 2023
revised: 01 03 2023
medline: 15 5 2023
pubmed: 8 3 2023
entrez: 7 3 2023
Statut: ppublish

Résumé

The objective is to determine whether a medical treatment, the combination of cefotaxime and rifampicin, is effective in avoiding surgery for managing deep cervical abscesses in children and to determine prognostic factors in the efficacy of this medical treatment. This is a retrospective analysis of all patients under 18 presenting with para- or retro-pharyngeal abscess over the period 2010-2020 in two hospitals' pediatric otorhinolaryngology departments. One hundred six records were included. Multivariate analyses were performed to study the relationship between the prescription of the Cefotaxime-rifampicin protocol at the onset of the management and the use of surgery and to evaluate the prognostic factors of its efficacy. The 53 patients who received the cefotaxime-rifampicin protocol as first-line treatment (vs. 53 patients receiving a different protocol) required surgery less frequently: 7.5% versus 32.1%, validated by a Kaplan-Meier survival curve and a Cox model analysis adjusted for age and abscess size (Hazard Ratio = 0.21). This good outcome of the cefotaxime-rifampicin protocol was not demonstrated when it was instituted as a second-line treatment after the failure of a different protocol. An abscess larger than 32 mm at hospitalization was significantly associated with more frequent use of surgery in multivariate analysis adjusted for age and sex (Hazard Ratio = 8.5).    Conclusions: The cefotaxime-rifampicin protocol appears to be an effective first-line treatment in managing non-complicated deep cervical abscesses in children. What is Known: • Nowadays, medical treatment is preferred for managing deep neck abscesses in children. There has yet to be a consensus on the antibiotic therapy to be proposed. • Staphylococcus aureus and streptococci are the most frequent causative organisms. What is New: • The cefotaxime-rifampicin protocol introduced at first intention is effective, with only 7.5% of patients requiring drainage surgery. • The only risk factor for failure of the medical treatment is the initial size of the abscess.

Identifiants

pubmed: 36881146
doi: 10.1007/s00431-023-04917-1
pii: 10.1007/s00431-023-04917-1
doi:

Substances chimiques

Cefotaxime N2GI8B1GK7
Rifampin VJT6J7R4TR
Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2315-2324

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Georget E, Gauthier A, Brugel L et al (2014) Acute cervical lymphadenitis and infections of the retropharyngeal and parapharyngeal spaces in children. BMC Ear Nose Throat Disord 14:8. https://doi.org/10.1186/1472-6815-14-8
doi: 10.1186/1472-6815-14-8 pubmed: 25206314 pmcid: 4158388
Mungul S, Maharaj S (2019) Microbiology of paediatric deep neck space infection. Int J Pediatr Otorhinolaryngol 123:116–122. https://doi.org/10.1016/j.ijporl.2019.04.042
doi: 10.1016/j.ijporl.2019.04.042 pubmed: 31100706
Shimizu Y, Hidaka H, Ozawa D et al (2017) Clinical and bacteriological differences of deep neck infection in pediatric and adult patients: Review of 123 cases. Int J Pediatr Otorhinolaryngol 99:95–99. https://doi.org/10.1016/j.ijporl.2017.05.028
doi: 10.1016/j.ijporl.2017.05.028 pubmed: 28688574
Cheng J, Elden L (2013) Children with deep space neck infections: our experience with 178 children. Otolaryngol-Head Neck Surg Off J Am Acad Otolaryngol-Head Neck Surg 148:1037–1042. https://doi.org/10.1177/0194599813482292
doi: 10.1177/0194599813482292
Wong DKC, Brown C, Mills N et al (2012) To drain or not to drain – Management of pediatric deep neck abscesses: A case–control study. Int J Pediatr Otorhinolaryngol 76:1810–1813. https://doi.org/10.1016/j.ijporl.2012.09.006
doi: 10.1016/j.ijporl.2012.09.006 pubmed: 23089190
Mayor GP, Millán JM, Martínez‐Vidal A (2001) Is conservative treatment of deep neck space infections appropriate? Head Neck 23:126–133. https://doi.org/10.1002/1097-0347(200102)23:2%3c126::AID-HED1007%3e3.0.CO;2-N
doi: 10.1002/1097-0347(200102)23:2<126::AID-HED1007>3.0.CO;2-N
Hoffmann C, Pierrot S, Contencin P et al (2011) Retropharyngeal infections in children. Treatment strategies and outcomes. Int J Pediatr Otorhinolaryngol 75:1099–1103. https://doi.org/10.1016/j.ijporl.2011.05.024
doi: 10.1016/j.ijporl.2011.05.024 pubmed: 21705095
Johnston D, Schmidt R, Barth P (2009) Parapharyngeal and retropharyngeal infections in children: argument for a trial of medical therapy and intraoral drainage for medical treatment failures. Int J Pediatr Otorhinolaryngol 73:761–765. https://doi.org/10.1016/j.ijporl.2009.02.007
doi: 10.1016/j.ijporl.2009.02.007 pubmed: 19297031
Sichel J-Y, Dano I, Hocwald E et al (2002) Nonsurgical management of parapharyngeal space infections: a prospective study. Laryngoscope 112:906–910. https://doi.org/10.1097/00005537-200205000-00023
doi: 10.1097/00005537-200205000-00023 pubmed: 12150626
Demongeot N, Akkari M, Blanchet C et al (2022) Pediatric deep neck infections: Clinical description and analysis of therapeutic management. Arch Pediatr Organe Off Soc Francaise Pediatr 29:128–132. https://doi.org/10.1016/j.arcped.2021.11.011
doi: 10.1016/j.arcped.2021.11.011
Lawrence R, Bateman N (2017) Controversies in the management of deep neck space infection in children: an evidence-based review. Clin Otolaryngol 42:156–163. https://doi.org/10.1111/coa.12692
doi: 10.1111/coa.12692 pubmed: 27288654
Maharaj S, Mungul S, Ahmed S (2020) Deep neck space infections: changing trends in pediatric versus adult patients. J Oral Maxillofac Surg 78:394–399. https://doi.org/10.1016/j.joms.2019.11.028
doi: 10.1016/j.joms.2019.11.028 pubmed: 31881171
Fellner A, Marom T, Muallem-Kalmovich L et al (2017) Pediatric neck abscesses: No increase in methicillin-resistant Staphylococcus aureus. Int J Pediatr Otorhinolaryngol 101:112–116. https://doi.org/10.1016/j.ijporl.2017.07.021
doi: 10.1016/j.ijporl.2017.07.021 pubmed: 28964280
Yetmar ZA, Razi S, Nayfeh T et al (2022) Ceftriaxone versus antistaphylococcal antibiotics for definitive treatment of methicillin-susceptible Staphylococcus aureus infections: a systematic review and meta-analysis. Int J Antimicrob Agents 59:106486. https://doi.org/10.1016/j.ijantimicag.2021.106486
Smith CR, Petty BG, Hendrix CW et al (1989) Ceftriaxone compared with cefotaxime for serious bacterial infections. J Infect Dis 160:442–447. https://doi.org/10.1093/infdis/160.3.442
doi: 10.1093/infdis/160.3.442 pubmed: 2668428
Panosetti E (1992) Phlegmonous and abscess-forming ENT infections: comparative efficacy of ceftriaxone versus amoxicillin-clavulanic acid. ORL J Oto-Rhino-Laryngol Its Relat Spec 54:95–99. https://doi.org/10.1159/000276271
doi: 10.1159/000276271
Jacobs RF (1991) Efficacy and safety of cefotaxime in the management of pediatric infections. Infection 19(Suppl 6):S330-336. https://doi.org/10.1007/BF01715774
doi: 10.1007/BF01715774 pubmed: 1791079
Bongiorno D, Mongelli G, Stefani S, Campanile F (2018) Burden of Rifampicin- and Methicillin-Resistant Staphylococcus aureus in Italy. Microb Drug Resist Larchmt N 24:732–738. https://doi.org/10.1089/mdr.2017.0299
doi: 10.1089/mdr.2017.0299
Bae S, Kim ES, Lee YW et al (2023) Clinical and microbiological characteristics of rifampicin-resistant MRSA bacteraemia. J Antimicrob Chemother 78:531–539. https://doi.org/10.1093/jac/dkac428
doi: 10.1093/jac/dkac428 pubmed: 36537200
Al-Sabah B, Bin Salleen H, Hagr A et al (2004) Retropharyngeal abscess in children: 10-year study. J Otolaryngol 33:352. https://doi.org/10.2310/7070.2004.03077
doi: 10.2310/7070.2004.03077 pubmed: 15971649
Daya H, Lo S, Papsin BC et al (2005) Retropharyngeal and parapharyngeal infections in children: the Toronto experience. Int J Pediatr Otorhinolaryngol 69:81–86. https://doi.org/10.1016/j.ijporl.2004.08.010
doi: 10.1016/j.ijporl.2004.08.010 pubmed: 15627452
Har D, Solensky R (2017) Penicillin and beta-lactam hypersensitivity. Immunol Allergy Clin North Am 37:643–662. https://doi.org/10.1016/j.iac.2017.07.001
doi: 10.1016/j.iac.2017.07.001 pubmed: 28965632
Diallo T, Adjobimey M, Ruslami R et al (2018) Safety and side effects of Rifampin versus Isoniazid in children. N Engl J Med 379:454–463. https://doi.org/10.1056/NEJMoa1714284
doi: 10.1056/NEJMoa1714284 pubmed: 30067928
Craig FW, Schunk JE (2003) Retropharyngeal abscess in children: clinical presentation, utility of imaging, and current management. Pediatrics 111:1394–1398. https://doi.org/10.1542/peds.111.6.1394
doi: 10.1542/peds.111.6.1394 pubmed: 12777558
Page NC, Bauer EM, Lieu JEC (2008) Clinical features and treatment of retropharyngeal abscess in children. Otolaryngol Neck Surg 138:300–306. https://doi.org/10.1016/j.otohns.2007.11.033
doi: 10.1016/j.otohns.2007.11.033
Lepelletier D, Pinaud V, Le Conte P et al (2017) Is there an association between prior anti-inflammatory drug exposure and occurrence of peritonsillar abscess (PTA)? A national multicenter prospective observational case-control study. Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol 36:57–63. https://doi.org/10.1007/s10096-016-2770-1
doi: 10.1007/s10096-016-2770-1
Piroulas C, Devillers L, Souty C et al (2019) Non-steroids anti-inflammatory drugs and risk of peritonsillar abscess in pharyngitis: a French longitudinal study in primary care†. Fam Pract 36:425–430. https://doi.org/10.1093/fampra/cmy111
doi: 10.1093/fampra/cmy111 pubmed: 30423110
Nicollas R, Moreddu E, Le Treut-Gay C et al (2020) Ibuprofen as risk-factor for complications of acute anterior sinusitis in children. Eur Ann Otorhinolaryngol Head Neck Dis 137:99–103. https://doi.org/10.1016/j.anorl.2019.10.004
doi: 10.1016/j.anorl.2019.10.004 pubmed: 31627971
Goenka PK, Hall M, Shah SS et al (2021) Corticosteroids in the treatment of pediatric retropharyngeal and parapharyngeal abscesses. Pediatrics 148:e2020037010. https://doi.org/10.1542/peds.2020-037010
Tansey JB, Hamblin J, Mamidala M et al (2020) Dexamethasone use in the treatment of pediatric deep neck space infections. Ann Otol Rhinol Laryngol 129:376–379. https://doi.org/10.1177/0003489419890349
doi: 10.1177/0003489419890349 pubmed: 31762293
Villanueva-Fernández E, Casanueva-Muruáis R, Vivanco-Allende A et al (2022) Role of steroids in conservative treatment of parapharyngeal and retropharyngeal abscess in children. Eur Arch Oto Rhino L 279:5331–5338. https://doi.org/10.1007/s00405-022-07423-6
doi: 10.1007/s00405-022-07423-6

Auteurs

Céline Bory (C)

Department of Pediatric Otorhinolaryngology-Head and Neck Surgery, La Timone Children's Hospital, Aix-Marseille University, 264 rue Saint Pierre, 13385 Cedex 05, Marseille, France.
Department of Otorhinolaryngology-Head and Neck Surgery, Sainte Musse Hospital, Toulon, France.

Olivier Bory (O)

Department of Ambulatory Medicine, Louis Mourier Hospital, Université de Paris, Paris, France.

Bruno Guelfucci (B)

Department of Otorhinolaryngology-Head and Neck Surgery, Sainte Musse Hospital, Toulon, France.

Richard Nicollas (R)

Department of Pediatric Otorhinolaryngology-Head and Neck Surgery, La Timone Children's Hospital, Aix-Marseille University, 264 rue Saint Pierre, 13385 Cedex 05, Marseille, France. richard.nicollas@ap-hm.fr.

Eric Moreddu (E)

Department of Pediatric Otorhinolaryngology-Head and Neck Surgery, La Timone Children's Hospital, Aix-Marseille University, 264 rue Saint Pierre, 13385 Cedex 05, Marseille, France. eric.moreddu@ap-hm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH